University Of Sydney
Clinical trials sponsored by University Of Sydney, explained in plain language.
-
New imaging tech aims to sharpen liver cancer radiation
Disease control OngoingThis study looks at whether a special imaging technique called KIM can help doctors deliver radiation more accurately to liver tumors. About 32 adults with liver cancer who cannot have surgery or a transplant will receive radiation with and without KIM tracking. The goal is to se…
Phase: NA • Sponsor: University of Sydney • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
New drug combo aims to stop high-risk prostate cancer from spreading
Disease control OngoingThis study tests whether adding enzalutamide to standard hormone therapy and radiation can delay cancer spread or death in men with high-risk localized prostate cancer. About 800 men will receive either standard treatment or standard treatment plus enzalutamide. The goal is to se…
Phase: PHASE3 • Sponsor: University of Sydney • Aim: Disease control
Last updated Jun 17, 2026 12:08 UTC
-
New drug combo aims to stop High-Risk prostate cancer from spreading
Disease control OngoingThis study tests whether adding darolutamide to standard hormone therapy and radiation can delay cancer spread in men with very high-risk localized prostate cancer. About 1,100 men are participating in this phase 3 trial. The goal is to see if the combination helps keep the cance…
Phase: PHASE3 • Sponsor: University of Sydney • Aim: Disease control
Last updated Jun 17, 2026 12:08 UTC